Missed the 2019 BIO CEO & Investor Conference? Download the Virtual Attendee Package here.

Monday, February 10

Tuesday, February 11

Wednesday, February 12 [optional Executive Leadership Course, EXTRA FEE]

Proposed Education Sessions

Therapeutic Topics

• Advances in Gene Therapy: Facing Challenges and Adapting for the Future
• Expanding the Toolkit for Fighting Solid Tumors
• Exploring Innovation in Cardiovascular Disease Therapeutics
• Neuroscience at the Crossroads: Late Stage Brain Disorder Pipelines and Unmet Needs
• Preparing for NASH and Other New Liver Treatments

Business Topics

• Commercialization Strategies for Communicating Evidence of a Therapy’s Value
• Election Outlook—Explaining Healthcare Policy Proposals’ Impacts on Innovation and Patients
• Industry Approaches for Hiring and Developing an Inclusive Workforce
• Market Outlook—Market Performance and IPO Class of 2020
• Shifting Tides: A Wall Street Perspective on Biotech Deal-making in the Current Global Climate

Statement on Diversity

BIO is committed to workforce development, diversity, and inclusion, and incorporates these values into all aspects of BIO operations. Program development for BIO’s events will be considered in this light, with specific attention paid to speakers’ gender, race, ethnic background, sexual orientation, and gender identity, as well as their company’s focus, financing, geographic location, and size.  Diverse programming at BIO’s events allows BIO to remain a strong leader in efforts to ensure that the biotechnology industry can attract, develop, and retain a high-quality, globally competitive employee talent pool. Learn more about Workforce Development, Diversity, & Inclusion at BIO.